Usana Health Sciences USNA reported its Q3 earnings results on Tuesday, October 26, 2021 at 04:17 PM.
Here's what investors need to know about the announcement.
Earnings
Usana Health Sciences beat their estimated earnings by 4.62%, which did not surprise analysts.
Revenue was up $24,161,000 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.16, which was followed by a 0.85% drop in the share price the next day.
Here's a look at Usana Health Sciences's past performance:
Quarter | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
---|---|---|---|---|
EPS Estimate | 1.71 | 1.48 | 1.43 | 1.25 |
EPS Actual | 1.87 | 1.45 | 1.87 | 1.44 |
Revenue Estimate | 332.61M | 301.47M | 291.54M | 277.26M |
Revenue Actual | 336.84M | 307.98M | 310.52M | 298.51M |
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Guidance
Usana Health Sciences management provided guidance for their next quarter, expecting earnings between $1.28 and $1.33 per share for the nextquarter.
This represents a -4.04% in quarter-over-quarter growth for Usana Health Sciences, a bearish signal to many investors.
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.